Abstract

To examine the therapeutic efficacy of Lianhua Qingwen granule combined with peramivir sodium chloride injection in treating influenza and level changes of serum inflammatory factors. The clinical data of 100 influenza sufferers enrolled in our infirmary from January 2018 to January 2020 retrospectively analyzed and they were randomized in the contrast group (n=50) and the experience group (n=50). The former was provided with peramivir sodium chloride injection, while the latter was medicated with Lianhua Qingwen granule after peramivir sodium chloride injection. The clinical efficacy, serum inflammatory factor, C-reactive protein, interleukin-6 level and procalcitonin level of both groups of sufferers were compared. The overall response rate of the injected group was 80 %, lower compared with 96 % of the injected and medicated group (p<0.05). The antipyretic time and sore throat disappearance time, cough disappearance time and general ache disappearance duration in the medicated group were remarkably shorter than those without Lianhua Qingwen powder (p<0.05). The differences in interleukin-6, C-reactive protein and procalcitonin levels before treatment between both groups were not statistically remarkable (p>0.05) and the levels of interleukin-6, C-reactive protein and procalcitonin of both groups of sufferers decreased after treatment. The levels of interleukin-6, C-reactive protein and procalcitonin of patients got injection and took medicine were remarkably lower than those who had no granule (p<0.05). Lianhua Qingwen granule combined with peramivir sodium chloride injection shows a remarkable potency in the treatment of influenza. It can shorten the treatment time and reduce the level of serum inflammatory factors. It is worthy of clinical promotion and application.